- Save $5 off $25, $10 off $50, or $15 off $100 when you pay with Bill Me Later®. Offer valid Oct 1, 2008 - Oct 12, 2008. Limited to items sold by Amazon.com. Subject to credit approval. One per customer. Enter code BMLDEALS at checkout. Here's how (restrictions apply)
Join Amazon Prime and ship Two-Day for free and Overnight for $3.99. Already a member? Sign in.
From Genome to Therapy
and over 180,000 other books are available for Amazon Kindle – Amazon’s new wireless reading device. Learn more
|
||||||||
Special Offers and Product Promotions
Editorial Reviews
Review
"It does successfully convey to the reader areas of controversy" (Microbiology Today, November 2001)
"there are a number of nuggets in the book that make it worth a browse." (Pharmaceutical Physician, December 2001)
"I found this book fun to read." (Biochemistry & Molecular Biology Education, No.29 2001)
"Contributors...present 17 papers and the discussions they generated at the symposium." (SciTech Book News, Vol. 25, No. 4, December 2001)
Product Description
This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.
This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.
"It does successfully convey to the reader areas of controversy" (Microbiology Today, November 2001)
"there are a number of nuggets in the book that make it worth a browse." (Pharmaceutical Physician, December 2001)
"I found this book fun to read." (Biochemistry & Molecular Biology Education, No.29 2001)
"Contributors...present 17 papers and the discussions they generated at the symposium." (SciTech Book News, Vol. 25, No. 4, December 2001)
Product Description
This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.
This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.